Project Grant HT94252510472
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$749K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
The Trustees of Indiana University were awarded a $3,930,678 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2024 to target replication stress in pediatric and young adult osteosarcoma. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award...
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) program, provides $1,188,750.00 to support the "ANCESTRY-DEPENDENT STROMAL CELL FACTORS IN BREAST CANCER PROGRESSION" research project. The award will be performed by the Trustees of Indiana University, doing business as Indiana University, over the period from January 31, 2025 to January 30, 2028. This research aims to investigate...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,924 Project Grant to the Trustees of Indiana University to support a 3-year research project titled "EARLY IMMUNOLOGIC PRECISION TYPING AT-RISK FRACTURES TO PREDICT NONUNION". The project aims to characterize the temporal immune/inflammatory biomarker profile in patients with open tibial fractures and develop a predictive model to guide decision-making for musculoskeletal...
The Trustees of Indiana University received a $950,999 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2021 through May 2025 to target EZH2-HOTAIR in order to block platinum-induced ovarian cancer stem cell enrichment and reduce recurrence. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the...
Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
The Trustees of Indiana University were awarded a $1,562,299 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 to July 2025 to investigate the genomic determinants of PIK3CA mutation-driven breast cancer initiation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
Trustees of Indiana University was awarded a $3,953,620 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2023. The grant will fund preclinical testing of a TRPV4 antagonist for the treatment of hydrocephalus in a porcine model through April 30, 2027. Purdue University was issued a subaward as part of the project to use a recently characterized porcine model of post-hemorrhagic hydrocephalus to study hydrocephalic...
This $487,623 federal Project Grant, awarded on September 30, 2023 by the Defense Health Agency (DHA) under the Military Medical Research and Development CFDA program (12.420), supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The award recipient is the Trustees of Indiana University, doing business as Indiana University, a major public research university with extensive expertise in biomedical sciences research. The project aims to advance...